Outsourced Pharma App Notes & Case Studies

41. Next-Gen Bioprocess Monitoring: Smart Data Management And Analysis 10/14/2020

    A new platform that includes digital technologies/data management, process analytical technologies and intensified processing will drive next generation bioprocessing.

42. Methodologies To Characterize Bioavailability Enhancing Formulations 7/23/2020

    Formulators have many choices when it comes to bioavailability enhancement. Which to use for a given compound? Explore tools to predict performance of bioavailability-enhanced formulations.

43. AAV Process Development Guidance Based On Cost Modeling 3/16/2022

    Cost modeling can be a powerful tool to assist with prioritizing areas of focus for process improvement during process development and especially useful for processes producing viral vectors for gene therapies.

44. Managing Complex Global Drug Distribution And Expiry 1/12/2021

    A global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced. 

45. Single-Use Technology For The Most Extreme Processes 6/7/2021

    Downstream processing for biologic drugs often requires the use of harsh chemicals that can damage SUT components. CPC designers identified a polymer that helped reproduce an AseptiQuik connectors to handle rough downstream chemicals.

46. Improving The Patient Experience Without Sacrificing Quality Of Care 5/20/2020

    Oncology drugs have rapidly evolved, but the delivery technology for IV- and syringe-based oncology drug treatments has not changed as quickly. Now, West’s SmartDose® platform expands patient access to SC delivery via a large-volume device that attaches to the patient. This gives the patient more freedom of movement at the infusion center or allows administration to occur at a different location.

47. Commercial Manufacturing In Half The Time 9/1/2021

    Due to FDA requirements for commercial manufacturing of regulated (GMP) intermediates, a global company needed a dedicated facility to produce its commercial antibiotic intermediate.

48. Capture Of Histidine-Tagged Molecules Using Biacore His Capture Kit 10/21/2021

    Find recommendations for immobilization of histidine-tagged molecules (ligands) by capture to an anti-histidine antibody covalently coupled to a sensor chip surface.

49. Biopharmaceutical Manufacturing: Why Australia? 2/23/2022

    World-class researchers, state-of-the-art facilities, a streamlined regulatory framework, and generous tax incentives have made Australia a prime location for the biotech industry.

50. Enhance Reaction Rates For Anti-Cancer Therapy Manufacture 4/8/2022

    Applying flow chemistry techniques allowed for a new route for an experimental anti-cancer therapy which included LED-NMR reaction profiling, quantum yield measurements and Stern-Volmer quenching studies.